Wegovy, Ozempic, and Mounjaro are being highly advertised as the little risk, high-reward drug that will not only make you lose weight, but also stay in shape. However, new research is citing that these drugs are doing more than expected, such as the possibility of removing desire altogether. (READ MORE: Ozempic Is Cheaper Than Ever. That’s Bad for Society.)
The Spectacle Podcast hosts Scott McKay and Melissa Mackenzie discuss the science behind GLP-1s and how these drugs alter one’s brain chemistry. Melissa shares her personal experience with GLP-1s and offers insight into how it impacts emotional and social behaviors. Melissa and Scott also talk about the importance of understanding addiction and how lifestyle changes fare better for weight management. (RELATED: We Unlocked the Secret to Beating Obesity. It’s Time to Act Like It.)
Tune in to hear their discussion!
Listen to The Spectacle with Melissa Mackenzie and Scott McKay on Spotify.
Watch The Spectacle with Melissa Mackenzie and Scott McKay on Rumble.
